Previous Article | Next Article ![]()
J. Virol., Jun 1996, 3823-3833, Vol 70, No. 6
DJ Volsky, M Simm, M Shahabuddin, G Li, W Chao and MJ Potash
It is thought that interference during human immunodeficiency virus type 1
(HIV-1) infection is established by downmodulation of the principal virus
receptor, CD4. Here we present evidence to the contrary. At various times
after primary infection, we superinfected T cells in vitro by exposure to a
genetically distinct viral clone or to a virus carrying the chloramphenicol
acetyltransferase gene. Replication of each virus strain was determined by
restriction enzyme analysis of total cellular DNA, by PCR amplification of
viral DNA, or by assay of cell extracts for chloramphenicol
acetyltransferase activity. We found that efficient viral interference is
established within 24 h of infection at a multiplicity of infection of 1.
At that time, expression of viral structural proteins was low and infected
cells displayed undiminished levels of surface CD4 and were fully
susceptible to virus binding and fusion. Superinfection by either cell-
free HIV-1 or cocultivation was blocked. Cells resistant to superinfection
by HIV-1 remained susceptible to Moloney murine leukemia and vaccinia
viruses. No interference was observed 4 h after primary infection or in
cells infected with either UV-inactivated HIV-1 or a mutant virus defective
in virus-cell fusion activity, indicating that binding of primary virus to
CD4 is insufficient to prevent superinfection. The minimum viral
requirements for this interference are that HIV-1 must be able to enter
cells and synthesize viral DNA; Tat-mediated transcription is dispensable.
Our results support the existence of a novel pathway to interference to
HIV-1 infection, which we term postentry interference, which blocks
superinfection during intracellular phases of the virus life cycle.
Copyright © 1996, American Society for Microbiology
Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4
Molecular Virology Laboratory, St. Luke's-Roosevelt Hospital Center, New York 10019, USA. djv4@columbia.edu
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»